Mammary carcinoma: toward a realistic mouse model of incurable cancers

Maria Pérez-Lanzón; Maria Chiara Maiuri; Carlos Lopez-Otin; Guido Kroemer

doi:10.1080/2162402X.2023.2240613

OncoImmunology (Dec 2023)

Mammary carcinoma: toward a realistic mouse model of incurable cancers

Maria Pérez-Lanzón,
Maria Chiara Maiuri,
Carlos Lopez-Otin,
Guido Kroemer

Affiliations

Maria Pérez-Lanzón: Centre de Recherche des Cordeliers, Équipe Labellisée Par la Ligue Contre le Cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France
Maria Chiara Maiuri: Centre de Recherche des Cordeliers, Équipe Labellisée Par la Ligue Contre le Cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France
Carlos Lopez-Otin: Departamento de Bioquimica Y Biologia Molecular, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, Oviedo, Spain
Guido Kroemer: Centre de Recherche des Cordeliers, Équipe Labellisée Par la Ligue Contre le Cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Institut Universitaire de France, Paris, France

DOI: https://doi.org/10.1080/2162402X.2023.2240613
Journal volume & issue: Vol. 12, no. 1

Abstract

Read online

ABSTRACTAs long as breast cancer (BC) stays under immunosurveillance, it can be controlled by treatments eliciting anticancer immune responses. However, once BC escapes immunosurveillance, it becomes therapeutically uncontrollable. A paper in the Journal for ImmunoTherapy of Cancer describes a new hormone receptor-positive BC cell line generating incurable tumors in C57BL/6 mice.

Published in OncoImmunology

ISSN: 2162-402X (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.tandfonline.com/journals/koni

About the journal